Videos

71 million American adults have high cholesterol, which is a key risk factor for heart attacks. Despite advances in medicine, this number isn’t going down. That’s because current U.S. guidelines do not measure toward a cholesterol goal. That needs to change.

Despite price controls, prescription drug costs have gone up–especially for patients on Medicare. See how middlemen are distorting prices for America’s seniors and hurting heart patients the most.

Tatum Cushing suffered a heart attack at 28. To ensure patients like Tatum have access to the transformative therapies they need to manage chronic conditions, Congress must pass the MINI Act.

Heart patients don’t need extra “steps.” Reforming step therapy ensures heart patients don’t have to deal with another barrier between them and their care.

Patient advocate Ozzie Giglio was diagnosed with cardiac amyloidosis, a rare disease that causes the heart muscles to stiffen. But thanks to new advances in genetically targeted technologies, Ozzie can live a longer, healthier life.

The MINI Act would allow more time for research, investment and infrastructure in the development of novel therapies like genetically targeted technologies for heart patients.

Listen to Robert Popovian, PharmD, Anne Sydor, PhD, and Ryan Gough as they discuss the impact of the Inflation Reduction Act’s maximum fair price on patients.

Angie Peterson was diagnosed with FH. Her doctor recommended one treatment – but her insurance forced her on another.

People with hypertension need options, support and access to the treatment that works best for them.

Patients living with cardiovascular conditions need tailored, quality care. That’s where specialty pharmacies come in.

Listen to Michael Gibson, MS, MD, Chris Kelly and Ryan Gough as they discuss the need for ongoing innovation and how policy can encourage breakthrough treatments like genetically targeted technologies.